Skip to content

COVIDOM+: Longterm morbidity of SARS-CoV-2 infection and COVID-19 disease – consequences for health status and quality of life

COVIDOM+: Longterm morbidity of SARS-CoV-2 infection and COVID-19 disease – consequences for health status and quality of life

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00023742
Enrollment
3750
Registered
2020-12-10
Start date
2020-11-16
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Post-COVID-Syndrom (PCS) SARS-CoV-2 infection

Interventions

Group 1: People with long-lasting symptoms after a previous SARS-CoV-2 infection, i.e. long/post COVID. The long-term follow-up is based on a population-based recruitment of individuals at least 6 mo
a retrospective description of the acute course of the disease and prospective characterisation of the participants on an anamnestic, functional and molecular level is conducted. Group 2: Controls are

Sponsors

Forschungsnetzwerk der Universitätsmedizin zu COVID-19 (Netzwerk Universitätsmedizin, NUM), Koordinierungsstelle Charité Berlin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: PCR-confirmed SARS-CoV-2 infection, living in one of the target areas, age at least 18 years, written informed consent.

Exclusion criteria

Exclusion criteria: Acute SARS-CoV-2 infection or reinfection

Design outcomes

Primary

MeasureTime frame
Longterm morbidities and sequels of SARS-CoV-2 infections in the general population 6 to 12 months after infection. Additional visits are scheduled at intervals of 12 months each.

Secondary

MeasureTime frame
(1) Reduced Quality of Life and Health Status (2) Increased healthcare utilization

Countries

Germany

Contacts

Public ContactLennart Reinke

Klinik für Innere Medizin I, UKSH Kiel

info@covidom.de0431 500 22201

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026